Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05743595
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-02-14
Brief Title:
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed Unmethylated Glioblastoma
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-14
First Submit QC Date:
February 14 2023
Study First Post Date:
2023-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL